Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Investigation of ( S)-(-)-Acidomycin: A Selective Antimycobacterial Natural Product That Inhibits Biotin Synthase.

Bockman MR, Engelhart CA, Cramer JD, Howe MD, Mishra NK, Zimmerman M, Larson P, Alvarez-Cabrera N, Park SW, Boshoff HIM, Bean JM, Young VG Jr, Ferguson DM, Dartois V, Jarrett JT, Schnappinger D, Aldrich CC.

ACS Infect Dis. 2019 Apr 12;5(4):598-617. doi: 10.1021/acsinfecdis.8b00345. Epub 2019 Feb 4.

PMID:
30652474
2.

Blood transcriptomic markers of Mycobacterium tuberculosis load in sputum.

Dupnik KM, Bean JM, Lee MH, Jean Juste MA, Skrabanek L, Rivera V, Vorkas CK, Pape JW, Fitzgerald DW, Glickman M.

Int J Tuberc Lung Dis. 2018 Aug 1;22(8):950-958. doi: 10.5588/ijtld.17.0855.

3.

Mass Spectrometric Identification of Urinary Biomarkers of Pulmonary Tuberculosis.

Isa F, Collins S, Lee MH, Decome D, Dorvil N, Joseph P, Smith L, Salerno S, Wells MT, Fischer S, Bean JM, Pape JW, Johnson WD, Fitzgerald DW, Rhee KY.

EBioMedicine. 2018 May;31:157-165. doi: 10.1016/j.ebiom.2018.04.014. Epub 2018 Apr 22.

4.

Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed.

Wipperman MF, Fitzgerald DW, Juste MAJ, Taur Y, Namasivayam S, Sher A, Bean JM, Bucci V, Glickman MS.

Sci Rep. 2017 Sep 7;7(1):10767. doi: 10.1038/s41598-017-10346-6.

5.

Structure and function of the mycobacterial transcription initiation complex with the essential regulator RbpA.

Hubin EA, Fay A, Xu C, Bean JM, Saecker RM, Glickman MS, Darst SA, Campbell EA.

Elife. 2017 Jan 9;6. pii: e22520. doi: 10.7554/eLife.22520.

6.

The effects of molecular noise and size control on variability in the budding yeast cell cycle.

Di Talia S, Skotheim JM, Bean JM, Siggia ED, Cross FR.

Nature. 2007 Aug 23;448(7156):947-51. Erratum in: Nature. 2007 Dec 20;450(7173):1272.

PMID:
17713537
7.
8.

Ribosome biogenesis is sensed at the Start cell cycle checkpoint.

Bernstein KA, Bleichert F, Bean JM, Cross FR, Baserga SJ.

Mol Biol Cell. 2007 Mar;18(3):953-64. Epub 2006 Dec 27.

9.

Coherence and timing of cell cycle start examined at single-cell resolution.

Bean JM, Siggia ED, Cross FR.

Mol Cell. 2006 Jan 6;21(1):3-14.

11.

Standard vs conformal radiation therapy for adenocarcinoma of the prostate: no difference.

Bean JM, Montana GS, Clough RW, King SC, Bentel GC, Marks LB, Anscher MS.

Prostate Cancer Prostatic Dis. 1998 Jun;1(4):216-222.

12.

Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1.

Harkin DP, Bean JM, Miklos D, Song YH, Truong VB, Englert C, Christians FC, Ellisen LW, Maheswaran S, Oliner JD, Haber DA.

Cell. 1999 May 28;97(5):575-86.

13.

Impact of consolidation radiotherapy in patients with advanced breast cancer treated with high-dose chemotherapy and autologous bone marrow rescue.

Carter DL, Marks LB, Bean JM, Broadwater G, Hussein A, Vredenburgh JJ, Peters WP, Prosnitz LR.

J Clin Oncol. 1999 Mar;17(3):887-93.

PMID:
10071280
14.

Heterozygous ATM mutations do not contribute to early onset of breast cancer.

FitzGerald MG, Bean JM, Hegde SR, Unsal H, MacDonald DJ, Harkin DP, Finkelstein DM, Isselbacher KJ, Haber DA.

Nat Genet. 1997 Mar;15(3):307-10.

PMID:
9054948
15.

Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma.

Brizel DM, Scully SP, Harrelson JM, Layfield LJ, Bean JM, Prosnitz LR, Dewhirst MW.

Cancer Res. 1996 Mar 1;56(5):941-3.

16.

Kids Health Day: one community hospital's approach to health education for families.

Bean JM, Hutchinson PA.

Patient Educ Couns. 1996 Jan;27(1):53-62.

PMID:
8788749
17.

Breast conservation therapy for intraductal carcinoma of the breast.

Kuske RR, Bean JM, Garcia DM, Perez CA, Andriole D, Philpott G, Fineberg B.

Int J Radiat Oncol Biol Phys. 1993 Jun 15;26(3):391-6.

PMID:
8390417
18.

Conversion of a 3-desoxysteroid to 3-desoxyestrogen by human placental aromatase.

Cole PA, Bean JM, Robinson CH.

Proc Natl Acad Sci U S A. 1990 Apr;87(8):2999-3003.

Supplemental Content

Support Center